Friday 6 November 2026
Export PEN’s income statement to Excel — free account
Penumbra, Inc.
PEN Healthcare Medical Devices
Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.
- Revenue
- +15.6%
- EPS
- −8.29%
- Free cash flow
- −37.2%
- Total debt
- −10.3%
Quarter to September 2026, against a year earlier
319.96
1.15
−0.36%
Follow PEN
Alert me
Penumbra, Inc. (PEN) revenue by segment, product and region
Where the money comes from and where it goes
| Thrombectomy | 948 | 67.53% |
|---|---|---|
| Embolization and Other | 456 | 32.47% |
| Gross margin | 67.14% | |
| Operating margin | 13.48% | |
| Pre-tax margin | 14.61% |
Revenue by product or service $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thrombectomy | 948 67.53% | 815 68.26% | 677 63.99% | 511 60.34% | 438 58.56% | — | — | — | — | — | — | — | — |
| Embolization and Other | 456 32.47% | 379 31.74% | 381 36.01% | 336 39.66% | 310 41.44% | — | — | — | — | — | — | — | — |
| Neuro | — | — | — | — | — | 293 52.22% | 332 60.59% | 294 66.15% | 232 69.64% | 186 70.46% | 141 75.99% | 106 84.65% | 81 91.55% |
| Peripheral Vascular | — | — | — | — | — | 268 47.78% | 216 39.41% | 151 33.85% | 101 30.36% | 78 29.54% | 45 24.01% | 19 15.35% | 8 8.45% |
| Revenue | 1,404 | 1,195 | 1,059 | 847 | 748 | 560 | 547 | 445 | 334 | 263 | 186 | 126 | 89 |
Revenue by region $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 1,092 77.78% | 902 75.51% | 757 71.53% | 592 69.85% | 528 70.60% | 400 71.42% | 355 64.89% | 291 65.34% | 219 65.67% | 176 66.88% | 127 68.41% | 83 66.10% | 58 65.62% |
| International | 312 22.22% | 293 24.49% | 301 28.47% | 255 30.15% | 220 29.40% | 160 28.58% | 192 35.11% | 154 34.66% | 81 24.21% | 57 21.62% | 40 21.37% | 28 22.19% | 18 20.12% |
| Japan | — | — | — | — | — | — | — | — | 34 10.12% | 30 11.50% | 19 10.22% | 15 11.71% | 13 14.26% |
| Revenue | 1,404 | 1,195 | 1,059 | 847 | 748 | 560 | 547 | 445 | 334 | 263 | 186 | 126 | 89 |